Mucormycosis, or "black fungus" usually infects people whose immune
system has been compromised, causing blackening or discolouration
over the nose, blurred or double vision, chest pain, breathing
difficulties and coughing blood.
Doctors believe that the use of steroids to treat severe COVID-19
could be causing the rash of cases because those drugs reduce
immunity and push up sugar levels.
Health Secretary Lav Agarwal said in a letter to state governments
that mucormycosis had emerged as a new challenge for COVID-19
patients on steroid therapy and those with pre-existing diabetes.
"This fungal infection is leading to prolonged morbidity and
mortality among COVID-19 patients," he said in the letter reviewed
by Reuters on Thursday.
He gave no numbers of the Mucormycosis cases nationwide but
Maharashtra, one of the states worst hit in the second wave of
coronavirus infections, has reported 1,500 cases of it.
Agarwal asked state governments to declare it as a "notifiable
disease" under the Epidemics Act, meaning they have to identify and
track every case.
India on Thursday reported 276,110 new coronavirus infections over
the previous 24 hours, slightly higher than a day earlier but well
below the 400,000 high seen at the beginning of this month in a
devastating second wave.
[to top of second column] |
The total caseload stands at
25.77 million, the world's second highest after
the United States. Deaths rose by 3,874
overnight, taking the total tally 287,122.
But with hospitals and crematoria overflowing and the health system
overwhelmed, it is widely accepted that the official figures grossly
underestimate the real impact of the epidemic, with some experts
saying infections and deaths could be five to 10 times higher.
The second wave has penetrated deep into the countryside and the
additional burden of mucormycosis has hit a rural health system
ill-equipped to cope.
SP Kalantari, a doctor based in Sevagram, a town in Maharashtra,
said that a team including ear, nose, and throat surgeons,
ophthalmologists and neurologists was needed to treat mucormycosis.
"Unfortunately, this kind of team does not exist in rural areas,"
Kalantari said.
(Reporting by Manas Mishra and Sai Sachin Ravikumar in Bengaluru,
Sudarshan Varadhan in Chennai; Editing by Sanjeev Miglani, Robert
Birsel)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content
|